Literature DB >> 21828978

The importance of good data, analysis, and interpretation for showing the economics of reducing healthcare-associated infection.

Nicholas Graves, Adrian G Barnett, Kate Halton, Christopher Crnich, Ben Cooper, Jan Beyersmann, Martin Wolkewitz, Matthew Samore, Stephan Harbarth.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21828978     DOI： 10.1086/661600

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  5 in total

Review 1.  Surgical Site Infection: The Clinical and Economic Impact.

Authors:  Megan C Turner; John Migaly
Journal:  Clin Colon Rectal Surg       Date:  2019-04-02

2.  A competing risks approach for nonparametric estimation of transition probabilities in a non-Markov illness-death model.

Authors:  Arthur Allignol; Jan Beyersmann; Thomas Gerds; Aurélien Latouche
Journal:  Lifetime Data Anal       Date:  2013-06-27       Impact factor: 1.588

3.  Costs and prolonged length of stay of central venous catheter-associated bloodstream infections (CVC BSI): a matched prospective cohort study.

Authors:  R Leistner; E Hirsemann; A Bloch; P Gastmeier; C Geffers
Journal:  Infection       Date:  2013-07-03       Impact factor: 3.553

4.  Costs associated with health care-associated infections in cardiac surgery.

Authors:  Giampaolo Greco; Wei Shi; Robert E Michler; David O Meltzer; Gorav Ailawadi; Samuel F Hohmann; Vinod H Thourani; Michael Argenziano; John H Alexander; Kathy Sankovic; Lopa Gupta; Eugene H Blackstone; Michael A Acker; Mark J Russo; Albert Lee; Sandra G Burks; Annetine C Gelijns; Emilia Bagiella; Alan J Moskowitz; Timothy J Gardner
Journal:  J Am Coll Cardiol       Date:  2015-01-06       Impact factor: 24.094

5.  Cost and effects of different admission screening strategies to control the spread of methicillin-resistant Staphylococcus aureus.

Authors:  Tanya Gurieva; Martin C J Bootsma; Marc J M Bonten
Journal:  PLoS Comput Biol       Date:  2013-02-21       Impact factor: 4.475
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.